HomeInsightsMarket Capitalization

Market Capitalization of Kwality Pharmaceuticals Ltd

Market Capitalization of Kwality Pharmaceuticals Ltd

stocks purchased

₹ 2.2 Cr

Volume Transacted

(Jan 3, 2025)

stocks purchased

23.7 K

Stocks Traded

(Jan 3, 2025)

Last Updated on: Jan 05, 2025

Image

Kwality Pharmaceuticals Ltd

NSE: KWALITYPHARMA

Market Cap

₹ 957.77 crore

Last updated on: Jan 03, 2025

Key Highlights

  • The Market Cap of Kwality Pharmaceuticals Ltd is ₹ 957.77 crore as of 03 Jan 25 .
  • The Market Cap of Kwality Pharmaceuticals Ltd changed from ₹ 26.51 crore on March 2020 to ₹ 424.8 crore on March 2024 . This represents a CAGR of 74.16% over 5 years.
  • The Latest Trading Price of Kwality Pharmaceuticals Ltd is ₹ 923.05 as of 03 Jan 15:30 .
  • The Dividend Payouts of Kwality Pharmaceuticals Ltd is ₹ 0.6 as of Jan 05, 2017 .

Historical Market Cap of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Company Fundamentals for Kwality Pharmaceuticals Ltd

No data available

Image

Kwality Pharmaceuticals Ltd

NSE: KWALITYPHARMA

Share Price

₹ 923.05

18.35 (2.03%)

stock direction

Last updated on: Jan 03, 2025

Market Price of Kwality Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Kwality Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
03 Jan 2025923.05
02 Jan 2025904.7
01 Jan 2025867.3
31 Dec 2024866.8
30 Dec 2024870.5
27 Dec 2024888.9
26 Dec 2024877.85
24 Dec 2024896.65
23 Dec 2024879.8
20 Dec 2024854.15

SWOT Analysis Of Kwality Pharmaceuticals Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Kwality Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Kwality Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Kwality Pharmaceuticals Ltd

No data available

No data available

Historical P/E Ratio of Kwality Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Image

Kwality Pharmaceuticals Ltd

NSE: KWALITYPHARMA

DIVIDENDPAYOUT

₹ 1

Last updated on: Jan 05, 2025

About Kwality Pharmaceuticals Ltd

  • Kwality Pharmaceuticals Limited was Incorporated on May 4th 1983 when its founder Mr. Ramesh Arora was inspired to begin his own venture leaving behind the already flourishing family business of spinning and aromatics.
  • With little background of finished pharmaceuticals and high held spirits and will, he started this business.
  • He received his first drug license in 1981 approved for liquid oral manufacturing.
  • Presently, the Company has 48 different sections available at their production centres. Kwality Pharmaceuticals Ltd. are manufacturer of finished pharmaceutical formulations in a Liquid Orals, Dry Syrups, Tablets, Capsules, Sterile Powder for Injections and small volume injectables.
  • The Company has the most modern & sophisticated Plant, Equipment, technique, and workforce.

Kwality Pharmaceuticals Ltd News Hub

News

Kwality Pharmaceuticals update on pre-clinical studies of Erythropoietin

Kwality Pharmaceuticals (KPL) has secured approval from the Review Committee on Genetic Ma...

Read more

02 Jan 2025 15:37

News

Kwality Pharma gains on securing RCGM approval for Erythropoietin

Erythropoietin is a critical therapeutic used to treat anemia associated with chronic kidn...

Read more

02 Jan 2025 14:28

News

Kwality Pharma gains on securing SAHPRA approval for Tamoxifen tablet

The approval was granted through a site transfer process for the company's prominent oncol...

Read more

24 Dec 2024 15:07

News

Kwality Pharma gains on receiving nod for PEGylated-Asparaginase

L-Asparaginase is an E. coli-derived enzyme primarily used in the treatment of acute lymph...

Read more

26 Nov 2024 11:55

News

Kwality Pharmaceuticals to hold board meeting

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30...

Read more

23 Oct 2024 10:21

News

Kwality Pharmaceuticals schedules AGM

Kwality Pharmaceuticals announced that the Annual General Meeting (AGM) of the company wil...

Read more

10 Sep 2024 10:31

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Kwality Pharmaceuticals Ltd Market Cap

What is the market cap of Kwality Pharmaceuticals Ltd?

As of January 5, 2025, Kwality Pharmaceuticals Ltd has a market capitalization of ₹957.77, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Kwality Pharmaceuticals Ltd's market capitalization?

Kwality Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Kwality Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Kwality Pharmaceuticals Ltd's market capitalization change?

Kwality Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions